Literature DB >> 22681939

Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children.

Michael P Blair1, Michael J Shapiro, M Elizabeth Hartnett.   

Abstract

PURPOSE: To estimate the normal distance from vascular termini to ora serrata in children's eyes.
METHODS: Clinical records and peripheral fluorescein angiography images of the ora serrata region, taken using scleral indentation and the RetCam system during examination under anesthesia, were retrospectively reviewed from consecutive patients with presumed normal peripheral retinal vasculature. All patients had ocular disease either only in the fellow eye or if in the study eye, to a degree judged not likely to affect peripheral retinal vascular development.
RESULTS: The record review identified 33 eyes of 31 patients with presumed normal peripheral vasculature. Mean age at angiography was 3.8 years (range, 2 months to 13 years). Mean area of nonperfusion was 0.9 disk diameters (DD) temporally (range, 1.5-0.5 DD; SD 0.3) and 0.6 DD nasally (range, 1-0.25 DD; SD 0.2).
CONCLUSIONS: In children up to 13 years of age, the avascular retina normally extends 1.5 DD or less temporally and 1.0 DD or less nasally from the ora serrata. Conservatively, ≥ 2 DD of nonperfusion, 3 standard deviations more than normal, should be considered abnormal and a sign of peripheral nonperfusion. These data may serve as preliminary indicators of the range of normal when evaluating diseases with retinal vascular abnormalities in children.
Copyright © 2012 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22681939      PMCID: PMC3756139          DOI: 10.1016/j.jaapos.2011.12.157

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  9 in total

1.  Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.

Authors:  S Hughes; H Yang; T Chan-Ling
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

2.  The angiographic pattern of the peripheral retinal vasculature.

Authors:  G K Asdourian; M F Goldberg
Journal:  Arch Ophthalmol       Date:  1979-12

3.  Fundus appearance in normal eyes. II. The standard peripheral fundus and developmental variations.

Authors:  U Rutnin; C L Schepens
Journal:  Am J Ophthalmol       Date:  1967-11       Impact factor: 5.258

4.  Fundus appearance in normal eyes. 3. Peripheral degenerations.

Authors:  U Rutnin; C L Schepens
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

5.  Fundus appearance in normal eyes. IV. Retinal breaks and other findings.

Authors:  U Rutnin; C L Schepens
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

6.  Bilateral fluorescein angiographic findings in unilateral Coats' disease.

Authors:  Thomas S Shane; Audina M Berrocal; Ditte J Hess
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-02-10

7.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Authors:  Helen A Mintz-Hittner; Kathleen A Kennedy; Alice Z Chuang
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

8.  Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.

Authors:  G C Black; R Perveen; R Bonshek; M Cahill; J Clayton-Smith; I C Lloyd; D McLeod
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

9.  Fluorescein angiography in inflammation of the peripheral fundus: the normal fluorescein angiographic pattern. I.

Authors:  H J Zenker
Journal:  Ophthalmologica       Date:  1985       Impact factor: 3.250

  9 in total
  16 in total

1.  Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

Authors:  Helen A Mintz-Hittner; Megan M Geloneck; Alice Z Chuang
Journal:  Ophthalmology       Date:  2016-05-27       Impact factor: 12.079

2.  Ultra-wide-field scanning laser ophthalmoscopy assists in the clinical detection and evaluation of asymptomatic early-stage familial exudative vitreoretinopathy.

Authors:  Jiao Lyu; Qi Zhang; Shi-Yuan Wang; Yi-Ye Chen; Yu Xu; Pei-Quan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-14       Impact factor: 3.117

3.  Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography.

Authors:  Aslı Vural; İrfan Perente; İsmail Umut Onur; Erdem Eriş; Zeynep Seymen; Gülsüm Oya Hergünsel; Özgül Salihoğlu; Fadime Ulviye Yiğit
Journal:  Int Ophthalmol       Date:  2018-11-26       Impact factor: 2.031

4.  Non-contact ultra-widefield retinal imaging of infants with suspected abusive head trauma.

Authors:  I H Yusuf; J K Barnes; T H M Fung; J S Elston; C K Patel
Journal:  Eye (Lond)       Date:  2017-02-24       Impact factor: 3.775

5.  The role of retinal imaging in the management of abusive head trauma cases.

Authors:  Antonio Oliva; Simone Grassi; Francesca Cazzato; Sayena Jabbehdari; Lorenzo Mensi; Giulia Amorelli; Lorenzo Orazi; Vincenzo Arena; Domenico Lepore
Journal:  Int J Legal Med       Date:  2022-01-24       Impact factor: 2.686

6.  Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: Follow-up to age 6 years.

Authors:  Hande Celiker; Ozlem Sahin
Journal:  Int Ophthalmol       Date:  2021-11-02       Impact factor: 2.031

7.  Repeated intravitreal ranibizumab for reactivated retinopathy of prematurity after intravitreal ranibizumab monotherapy: vascular development analysis.

Authors:  Fengjie Xia; Jiao Lyu; Jie Peng; Peiquan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-19       Impact factor: 3.535

8.  Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression.

Authors:  Aslı Vural; Dilbade Yıldız Ekinci; Ismail Umut Onur; Gülsüm Oya Hergünsel; Fadime Ulviye Yiğit
Journal:  Int Ophthalmol       Date:  2019-01-02       Impact factor: 2.031

9.  Evaluation of Potential Systemic Adverse Events Related to Fluorescein Angiography in Pediatric Patients.

Authors:  Ru-Ik Chee; Mrinali P Gupta; Nita G Valikodath; Emily Cole; Anton Orlin; Tala Al-Khaled; Irene Rusu; Samir N Patel; June Han; Vivien Yap; Karyn E Jonas; Peter J Campbell; Michael F Chiang; R V Paul Chan
Journal:  Ophthalmol Retina       Date:  2019-12-16

10.  Retinal Features of Family Members With Familial Exudative Vitreoretinopathy Caused By Mutations in KIF11 Gene.

Authors:  Hiroyuki Kondo; Itsuka Matsushita; Tatsuo Nagata; Etsuko Fujihara; Katsuhiro Hosono; Eiichi Uchio; Yoshihiro Hotta; Shunji Kusaka
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.